相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CRISPR-Cas System: The Powerful Modulator of Accessory Genomes in Prokaryotes
Anca Butiuc-Keul et al.
MICROBIAL PHYSIOLOGY (2022)
A novel combination therapy for multidrug resistant pathogens using chitosan nanoparticles loaded with β-lactam antibiotics and β-lactamase inhibitors
Peixin Fan et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2022)
Enzyme Inhibitors: The Best Strategy to Tackle Superbug NDM-1 and Its Variants
Xiaoting Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Impact of PBP4 Alterations on β-Lactam Resistance and Ceftobiprole Non-Susceptibility Among Enterococcus faecalis Clinical Isolates
Lorenzo M. Lazzaro et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2022)
Potentiation of β-Lactams against Methicillin-Resistant Staphylococcus aureus (MRSA) Using Octyl Gallate, a Food-Grade Antioxidant
Migma Dorji Tamang et al.
ANTIBIOTICS-BASEL (2022)
Human defensin-inspired discovery of peptidomimetic antibiotics
Gan Luo et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)
Metabolomics in antimicrobial drug discovery
Rustam Aminov
EXPERT OPINION ON DRUG DISCOVERY (2022)
Molecular docking and proteomics reveals the synergistic antibacterial mechanism of theaflavin with β-lactam antibiotics against MRSA
Shuhan Guan et al.
FRONTIERS IN MICROBIOLOGY (2022)
Double-, single- and none-carbapenem-containing regimens for the treatment of carbapenem-resistant Enterobacterales (CRE) bloodstream infections: a retrospective cohort
Maria Helena Rigatto et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2022)
Antibiotic Potentiators Against Multidrug-Resistant Bacteria: Discovery, Development, and Clinical Relevance
Meenal Chawla et al.
FRONTIERS IN MICROBIOLOGY (2022)
Discovery of thiosemicarbazone derivatives as effective New Delhi metallo-beta-lactamase-1 (NDM-1) inhibitors against NDM-1 producing clinical isolates
Bing Zhao et al.
ACTA PHARMACEUTICA SINICA B (2021)
Simultaneous elucidation of antibiotic mechanism of action and potency with high-throughput Fourier-transform infrared (FTIR) spectroscopy and machine learning
Bernardo Ribeiro da Cunha et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2021)
Are antibacterial effects of non-antibiotic drugs random or purposeful because of a common evolutionary origin of bacterial and mammalian targets?
Axel Dalhoff
INFECTION (2021)
The Odd Couple(s): An Overview of Beta-Lactam Antibiotics Bearing More Than One Pharmacophoric Group
Margherita De Rosa et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Discovery of beta-lactamase CMY-10 inhibitors for combination therapy against multi-drug resistant Enterobacteriaceae
Nousheen Parvaiz et al.
PLOS ONE (2021)
Discovery of potential inhibitors against New Delhi metallo-β-lactamase-1 from natural compounds: in silico-based methods
Azhar Salari-jazi et al.
SCIENTIFIC REPORTS (2021)
The effect of structural modification of antimicrobial peptides on their antimicrobial activity, hemolytic activity, and plasma stability
Taoran Wang et al.
JOURNAL OF PEPTIDE SCIENCE (2021)
Antimicrobial resistance and interspecies gene transfer in Campylobacter coli and Campylobacter jejuni isolated from food animals, poultry processing, and retail meat in North Carolina, 2018-2019
Dawn M. Hull et al.
PLOS ONE (2021)
Dipyridyl-substituted thiosemicarbazone as a potent broad-spectrum inhibitor of metallo-β-lactamases
Jia-Qi Li et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2021)
β-lactam Resistance in Pseudomonas aeruginosa: Current Status, Future Prospects
Karl A. Glen et al.
PATHOGENS (2021)
Metal and Metal Oxide Nanoparticle as a Novel Antibiotic Carrier for the Direct Delivery of Antibiotics
Harshada Kotrange et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
β-lactam resistance associated with β-lactamase production and porin alteration in clinical isolates of E. coli and K. pneumoniae
Sara M. Khalifa et al.
PLOS ONE (2021)
Nanoparticles as therapeutic options for treating multidrug-resistant bacteria: research progress, challenges, and prospects
Ifeanyi E. Mba et al.
WORLD JOURNAL OF MICROBIOLOGY & BIOTECHNOLOGY (2021)
QPX7728, An Ultra-Broad-Spectrum B-Lactamase Inhibitor for Intravenous and Oral Therapy: Overview of Biochemical and Microbiological Characteristics
Olga Lomovskaya et al.
FRONTIERS IN MICROBIOLOGY (2021)
Durlobactam, a New Diazabicyclooctane β-Lactamase Inhibitor for the Treatment of Acinetobacter Infections in Combination With Sulbactam
Adam B. Shapiro et al.
FRONTIERS IN MICROBIOLOGY (2021)
Antibiotic Potentiation in Multidrug-Resistant Gram-Negative Pathogenic Bacteria by a Synthetic Peptidomimetic
Elnaz Harifi Mood et al.
ACS INFECTIOUS DISEASES (2021)
Pharmacokinetics of Non-β-Lactam β-Lactamase Inhibitors
Giacomo Luci et al.
ANTIBIOTICS-BASEL (2021)
Multidrug-Resistant Klebsiella pneumoniae Causing Severe Infections in the Neuro-ICU
Nadezhda K. Fursova et al.
ANTIBIOTICS-BASEL (2021)
Combination of silver nanoparticles with ineffective antibiotics against extended spectrum beta-lactamases producing isolates at Alexandria Main University Hospital, Egypt
Asmaa Sabry Abdrabou Mohammed et al.
BENI-SUEF UNIVERSITY JOURNAL OF BASIC AND APPLIED SCIENCES (2021)
The Global Ascendency of OXA-48-Type Carbapenemases
Johann D. D. Pitout et al.
CLINICAL MICROBIOLOGY REVIEWS (2020)
Safety and Pharmacokinetic Characterization of Nacubactam, a Novel β-Lactamase Inhibitor, Alone and in Combination with Meropenem, in Healthy Volunteers
Navita L. Mallalieu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Mechanism-of-Action Classification of Antibiotics by Global Transcriptome Profiling
Aubrie O'Rourke et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Discovery of Taniborbactam (VNRX-5133): A Broad-Spectrum Serine- and Metallo-β-lactamase Inhibitor for Carbapenem-Resistant Bacterial Infections
Bin Liu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
Antibiotic prescribing among patients with severe infectious diseases in two private sector hospitals in Central India - a time series analysis over 10 years
Anna Damlin et al.
BMC INFECTIOUS DISEASES (2020)
The Importance of Porins and β-Lactamase in Outer Membrane Vesicles on the Hydrolysis of β-Lactam Antibiotics
Si Won Kim et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Prevalence and Outcomes of Infection Among Patients in Intensive Care Units in 2017
Jean-Louis Vincent et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Machine Learning Algorithm Identifies an Antibiotic Vocabulary for Permeating Gram-Negative Bacteria
Rachael A. Mansbach et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2020)
Exploring the Potential of CRISPR-Cas9 Under Challenging Conditions: Facing High-Copy Plasmids and Counteracting Beta-Lactam Resistance in Clinical Strains of Enterobacteriaceae
Thaysa Leite Tagliaferri et al.
FRONTIERS IN MICROBIOLOGY (2020)
Thanatin Impairs Lipopolysaccharide Transport Complex Assembly by Targeting LptC-LptA Interaction and Decreasing LptA Stability
Elisabete C. C. M. Moura et al.
FRONTIERS IN MICROBIOLOGY (2020)
Small Molecule Carboxylates Inhibit Metallo-β-lactamases and Resensitize Carbapenem-Resistant Bacteria to Meropenem
Kamaleddin H. M. E. Tehrani et al.
ACS INFECTIOUS DISEASES (2020)
CRISPR-Cas9-Mediated Carbapenemase Gene and Plasmid Curing in Carbapenem-Resistant Enterobacteriaceae
Mingju Hao et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Adaptive laboratory evolution of Vibrio cholerae to doxycycline associated with spontaneous mutation
Lekshmi Narendrakumar et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Discovery of an Orally Available Diazabicyclooctane Inhibitor (ETX0282) of Class A, C, and D Serine β-Lactamases
Thomas F. Durand-Reville et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
In Vitro Activity of WCK 5222 (Cefepime-Zidebactam) against Worldwide Collected Gram-Negative Bacilli Not Susceptible to Carbapenems
James A. Karlowsky et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Virtual screening identifies broad-spectrum β-lactamase inhibitors with activity on clinically relevant serine- and metallo-carbapenemases
Francesca Spyrakis et al.
SCIENTIFIC REPORTS (2020)
Combining antibiotics with antivirulence compounds can have synergistic effects and reverse selection for antibiotic resistance in Pseudomonas aeruginosa
Chiara Rezzoagli et al.
PLOS BIOLOGY (2020)
Discovery of a Novel Natural Allosteric Inhibitor That Targets NDM-1 Against Escherichia coli
Yanan Yang et al.
FRONTIERS IN PHARMACOLOGY (2020)
Identification of the PA1113 Gene Product as an ABC Transporter Involved in the Uptake of Carbenicillin in Pseudomonas aeruginosa PAO1
Christian Hulen et al.
ANTIBIOTICS-BASEL (2020)
Transcriptome-based design of antisense inhibitors potentiates carbapenem efficacy in CRE Escherichia coli
Thomas R. Aunins et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Discovery of Novel Biosynthetic Gene Cluster Diversity From a Soil Metagenomic Library
Alinne L. R. Santana-Pereira et al.
FRONTIERS IN MICROBIOLOGY (2020)
β-lactamase-mediated resistance in MDR-Pseudomonas aeruginosa from Qatar
Mazen A. Sid Ahmed et al.
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2020)
Cefiderocol: A Novel Agent for the Management of Multidrug-Resistant Gram-Negative Organisms
Janet Y. Wu et al.
INFECTIOUS DISEASES AND THERAPY (2020)
New beta-Lactam-beta-Lactamase Inhibitor Combinations
Dafna Yahav et al.
CLINICAL MICROBIOLOGY REVIEWS (2020)
Beyond Piperacillin-Tazobactam: Cefepime and AAI101 as a Potent β-Lactam - β-Lactamase Inhibitor Combination
Krisztina M. Papp-Wallace et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
NDM Metallo-β-Lactamases and Their Bacterial Producers in Health Care Settings
Wenjing Wu et al.
CLINICAL MICROBIOLOGY REVIEWS (2019)
The nature and epidemiology of OqxAB, a multidrug efflux pump
Jun Li et al.
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2019)
Chemical Proteomics-Guided Identification of a Novel Biological Target of the Bioactive Neolignan Magnolol
Chiara Cassiano et al.
FRONTIERS IN CHEMISTRY (2019)
Metabolomics-Driven Exploration of the Chemical Drug Space to Predict Combination Antimicrobial Therapies
Adrian I. Campos et al.
MOLECULAR CELL (2019)
Application of Antimicrobial Peptides of the Innate Immune System in Combination With Conventional Antibiotics-A Novel Way to Combat Antibiotic Resistance?
Maria S. Zharkova et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2019)
Distinct Roles of Outer Membrane Porins in Antibiotic Resistance and Membrane Integrity in Escherichia coli
Umji Choi et al.
FRONTIERS IN MICROBIOLOGY (2019)
Antibiotic resistance breakers: current approaches and future directions
Mark Laws et al.
FEMS MICROBIOLOGY REVIEWS (2019)
A selective membrane-targeting repurposed antibiotic with activity against persistent methicillin-resistant Staphylococcus aureus
Wooseong Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Dual β-lactam combination therapy for multi-drug resistant Pseudomonas aeruginosa infection: enhanced efficacy in vivo and comparison with monotherapies of penicillin-binding protein inhibition
Thanyaluck Siriyong et al.
SCIENTIFIC REPORTS (2019)
Metagenome Driven Discovery of Nonribosomal Peptides
Luke J. Stevenson et al.
ACS CHEMICAL BIOLOGY (2019)
The latest advances in β-lactam/β-lactamase inhibitor combinations for the treatment of Gram-negative bacterial infections
Krisztina M. Papp-Wallace
EXPERT OPINION ON PHARMACOTHERAPY (2019)
Economic burden of antibiotic resistance in ESKAPE organisms: a systematic review
Xuemei Zhen et al.
ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL (2019)
WCK 5222 (Cefepime-Zidebactam) Pharmacodynamic Target Analysis against Metallo-β-Lactamase-Producing Enterobacteriaceae in the Neutropenic Mouse Pneumonia Model
Alexander J. Lepak et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
The antimicrobial peptide thanatin disrupts the bacterial outer membrane and inactivates the NDM-1 metallo-β-lactamase
Bo Ma et al.
NATURE COMMUNICATIONS (2019)
OXA-830, a Novel Chromosomally Encoded Extended-Spectrum Class D β-Lactamase in Aeromonas simiae
Qianqian Chen et al.
FRONTIERS IN MICROBIOLOGY (2019)
Polymyxin Derivatives that Sensitize Gram-Negative Bacteria to Other Antibiotics
Martti Vaara
MOLECULES (2019)
High Prevalence of Multidrug-Resistant Klebsiella pneumoniae Harboring Several Virulence and β-Lactamase Encoding Genes in a Brazilian Intensive Care Unit
Roumayne L. Ferreira et al.
FRONTIERS IN MICROBIOLOGY (2019)
Bio-surfactin stabilised silver nanoparticles exert inhibitory effect over New-Delhi metallo-beta-lactamases (NDMs) and the cells harbouring NDMs
Ganesh N. Kumar et al.
FEMS MICROBIOLOGY LETTERS (2019)
Current antibiotic use in the treatment of enteric fever in children
Sushila Dahiya et al.
INDIAN JOURNAL OF MEDICAL RESEARCH (2019)
Natural outer membrane permeabilizers boost antibiotic action against irradiated resistant bacteria
Hala A. Farrag et al.
JOURNAL OF BIOMEDICAL SCIENCE (2019)
Study of inhibitory potential and percent inhibition of oil of Syzygium aromaticum and leaves of Ocimum sanctum on ESBL enzyme from Escherichia coli in broilers of Jabalpur
Arpita Shrivastav et al.
INDIAN JOURNAL OF PHARMACOLOGY (2019)
A 2-Year Single-Centre Audit on Antibiotic Resistance of Pseudomonas aeruginosa, Acinetobacter baumannii and Klebsiella pneumoniae Strains from an Intensive Care Unit and Other Wards in a General Public Hospital in Greece
Georgios Feretzakis et al.
ANTIBIOTICS-BASEL (2019)
A Rapid Phenotypic Whole-Cell Screening Approach for the Identification of Small-Molecule Inhibitors That Counter β-Lactamase Resistance in Pseudomonas aeruginosa
Deanna Collia et al.
SLAS DISCOVERY (2018)
Discovery of a Novel Metallo-β-Lactamase Inhibitor That Potentiates Meropenem Activity against Carbapenem-Resistant Enterobacteriaceae
Martin Everett et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Potentiation of the activity of β-lactam antibiotics by farnesol and its derivatives
Choon Kim et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Characterization of β-lactamase- and efflux pump-mediated multiple antibiotic resistance in Salmonella Typhimurium
Md. Jalal Uddin et al.
FOOD SCIENCE AND BIOTECHNOLOGY (2018)
High-throughput metabolomic analysis predicts mode of action of uncharacterized antimicrobial compounds
Mattia Zampieri et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Role of efflux pump and OprD porin expression in carbapenem resistance of Pseudomonas aeruginosa clinical isolates
Tuba Muderris et al.
JOURNAL OF INFECTION IN DEVELOPING COUNTRIES (2018)
Proteomic identification of Axc, a novel beta-lactamase with carbapenemase activity in a meropenem-resistant clinical isolate of Achromobacter xylosoxidans
Frank Fleurbaaij et al.
SCIENTIFIC REPORTS (2018)
AmPEP: Sequence-based prediction of antimicrobial peptides using distribution patterns of amino acid properties and random forest
Pratiti Bhadra et al.
SCIENTIFIC REPORTS (2018)
Trans-Cinnamaldehyde and Eugenol Increase Acinetobacter baumannii Sensitivity to Beta-Lactam Antibiotics
Deepti P. Karumathil et al.
FRONTIERS IN MICROBIOLOGY (2018)
Total Syntheses of Bulgecins A, B, and C and Their Bactericidal Potentiation of the β-Lactam Antibiotics
Shusuke Tomoshige et al.
ACS INFECTIOUS DISEASES (2018)
In Vitro Activity of LYS228, a Novel Monobactam Antibiotic, against Multidrug-Resistant Enterobacteriaceae
Johanne Blais et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Successive Emergence of Ceftazidime-Avibactam Resistance through Distinct Genomic Adaptations in blaKPC-2-Harboring Klebsiella pneumoniae Sequence Type 307 Isolates
Marla J. Giddins et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2018)
Magnolol restores the activity of meropenem against NDM-1-producing Escherichia coli by inhibiting the activity of metallo-beta-lactamase
Shui Hu et al.
CELL DEATH DISCOVERY (2018)
Application of metabolomics to drug discovery and understanding the mechanisms of action of medicinal plants with anti-tuberculosis activity
Naasson Tuyiringire et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2018)
Classical β-Lactamase Inhibitors Potentiate the Activity of Daptomycin against Methicillin-Resistant Staphylococcus aureus and Colistin against Acinetobacter baumannii
George Sakoulas et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Emergence of ceftazidime/avibactam non-susceptibility in an MDR Klebsiella pneumoniae isolate
Anna Both et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Beta-lactamase database (BLDB) - structure and function
Thierry Naas et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2017)
Synthetic Antibacterial Peptide Exhibits Synergy with Oxacillin against MRSA
John C. Lainson et al.
ACS MEDICINAL CHEMISTRY LETTERS (2017)
Molecular characterization of β-lactamase genes in clinical isolates of carbapenem-resistant Acinetobacter baumannii
Kevin M. Raible et al.
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS (2017)
Clinical Guidelines for the Antibiotic Treatment for Community-Acquired Skin and Soft Tissue Infection
Yee Gyung Kwak et al.
INFECTION AND CHEMOTHERAPY (2017)
Conessine as a novel inhibitor of multidrug efflux pump systems in Pseudomonas aeruginosa
Thanyaluck Siriyong et al.
BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2017)
Safety and efficacy of a novel drug elores (ceftriaxone plus sulbactam plus disodium edetate) in the management of multi-drug resistant bacterial infections in tertiary care centers: a post-marketing surveillance study
Manu Chaudhary et al.
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES (2017)
WCK 5107 (Zidebactam) and WCK 5153 Are Novel Inhibitors of PBP2 Showing Potent β-Lactam Enhancer Activity against Pseudomonas aeruginosa, Including Multidrug-Resistant Metallo-β-Lactamase-Producing High-Risk Clones
Bartolome Moya et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Impact of a Cross-Kingdom Signaling Molecule of Candida albicans on Acinetobacter baumannii Physiology
Xenia Kostoulias et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Modeling Meropenem Treatment, Alone and in Combination with Daptomycin, for KPC-Producing Klebsiella pneumoniae Strains with Unusually Low Carbapenem MICs
P. Gagetti et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Antimicrobial photodynamic inactivation: a bright new technique to kill resistant microbes
Michael R. Hamblin
CURRENT OPINION IN MICROBIOLOGY (2016)
Heterogeneous oxacillin-resistant phenotypes and production of PBP2A by oxacillin-susceptible/mecA-positive MRSA strains from Africa
Marilyn Chung et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Clonal expansion of Escherichia coli ST38 carrying a chromosomally integrated OXA-48 carbapenemase gene
Jane F. Turton et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2016)
Structure-Function Analysis of the Transmembrane Protein AmpG from Pseudomonas aeruginosa
Peizhen Li et al.
PLOS ONE (2016)
Cross-class metallo-β-lactamase inhibition by bisthiazolidines reveals multiple binding modes
Philip Hinchliffe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
β-Lactams and β-Lactamase Inhibitors: An Overview
Karen Bush et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
Appearance of β-lactam Resistance Genes in Agricultural Soils and Clinical Isolates over the 20th Century
David W. Graham et al.
SCIENTIFIC REPORTS (2016)
Mechanisms of Antibiotic Resistance
Jose M. Munita et al.
MICROBIOLOGY SPECTRUM (2016)
Inhibiting the VIM-2 Metallo-β-Lactamase by Graphene Oxide and Carbon Nanotubes
Po-Jung Jimmy Huang et al.
ACS APPLIED MATERIALS & INTERFACES (2015)
Ebselen as a potent covalent inhibitor of New Delhi metallo-β-lactamase (NDM-1)
Jiachi Chiou et al.
CHEMICAL COMMUNICATIONS (2015)
A resurgence of β-lactamase inhibitor combinations effective against multidrug-resistant Gram-negative pathogens
Karen Bush
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2015)
Discovery of a Cyclic Boronic Acid β-Lactamase Inhibitor (RPX7009) with Utility vs Class A Serine Carbapenemases
Scott J. Hecker et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Multiplexed metagenome mining using short DNA sequence tags facilitates targeted discovery of epoxyketone proteasome inhibitors
Jeremy G. Owen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
An efficient system for intracellular delivery of beta-lactam antibiotics to overcome bacterial resistance
Nadia Abed et al.
SCIENTIFIC REPORTS (2015)
Imipenem heteroresistance: high prevalence among Enterobacteriaceae Klebsiella pneumoniae carbapenemase producers
Carolina Silva Nodari et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2015)
Antibiotic-containing polymers for localized, sustained drug delivery
Nicholas D. Stebbins et al.
ADVANCED DRUG DELIVERY REVIEWS (2014)
Role of OmpA in the Multidrug Resistance Phenotype of Acinetobacter baumannii
Younes Smani et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Discovery of MK-7655, a β-lactamase inhibitor for combination with Primaxin®
Timothy A. Blizzard et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
A Systematic Analysis of Biosynthetic Gene Clusters in the Human Microbiome Reveals a Common Family of Antibiotics
Mohamed S. Donia et al.
CELL (2014)
Chromosomal location of blaCTX-M genes in clinical isolates of Escherichia coli from Germany, The Netherlands and the UK
I. Rodriguez et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2014)
Aspergillomarasmine A overcomes metallo-β-lactamase antibiotic resistance
Andrew M. King et al.
NATURE (2014)
Controlling resistant bacteria with a novel class of β-lactamase inhibitor peptides: from rational design to in vivo analyses
Santi M. Mandal et al.
SCIENTIFIC REPORTS (2014)
Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases
L. Silvia Munoz-Price et al.
LANCET INFECTIOUS DISEASES (2013)
The Efflux Inhibitor Phenylalanine-Arginine Beta-Naphthylamide (PAβN) Permeabilizes the Outer Membrane of Gram-Negative Bacteria
Ryan P. Lamers et al.
PLOS ONE (2013)
The Mechanism of Heterogeneous Beta-Lactam Resistance in MRSA: Key Role of the Stringent Stress Response
Choonkeun Kim et al.
PLOS ONE (2013)
Identification of a Small-Molecule Inhibitor of Bacterial AraC Family Activators
Jeff M. Skredenske et al.
JOURNAL OF BIOMOLECULAR SCREENING (2013)
The Beta Lactam Antibiotics as an Empirical Therapy in a Developing Country: An Update on Their Current Status and Recommendations to Counter the Resistance against Them
Bhaskar Thakuria et al.
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH (2013)
High-Level Cefixime- and Ceftriaxone-Resistant Neisseria gonorrhoeae in France: Novel penA Mosaic Allele in a Successful International Clone Causes Treatment Failure
Magnus Unemo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Escherichia coli from Italy Producing OXA-48 Carbapenemase Encoded by a Novel Tn1999 Transposon Derivative
Tommaso Giani et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Expression of OXA-Type and SFO-1 β-Lactamases Induces Changes in Peptidoglycan Composition and Affects Bacterial Fitness
Ana Fernandez et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
In situ potentiometric method to evaluate bacterial outer membrane-permeabilizing ability of drugs: Example using antiprotozoal diamidines
Makoto Ando et al.
JOURNAL OF MICROBIOLOGICAL METHODS (2012)
Avibactam is a covalent, reversible, non-β-lactam β-lactamase inhibitor
David E. Ehmann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Carbapenems: Past, Present, and Future
Krisztina M. Papp-Wallace et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Combating Antimicrobial Resistance: Policy Recommendations to Save Lives
Robert J. Guidos et al.
CLINICAL INFECTIOUS DISEASES (2011)
Genome mining for ribosomally synthesized natural products
Juan E. Velasquez et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2011)
Artesunate enhances the antibacterial effect of β-lactam antibiotics against Escherichia coli by increasing antibiotic accumulation via inhibition of the multidrug efflux pump system AcrAB-TolC
Bin Li et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Characterization of IncF plasmids carrying the blaCTX-M-14 gene in clinical isolates of Escherichia coli from Korea
Juwon Kim et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Emergence of Klebsiella pneumoniae Carbapenemase-Producing Bacteria
Ryan S. Arnold et al.
SOUTHERN MEDICAL JOURNAL (2011)
Updated Functional Classification of beta-Lactamases
Karen Bush et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
New beta-lactam antibiotics and beta-lactamase inhibitors
Karen Bush et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2010)
Genome mining and genetic analysis of cypemycin biosynthesis reveal an unusual class of posttranslationally modified peptides
Jan Claesen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Molecular mechanisms disrupting porin expression in ertapenem-resistant Klebsiella and Enterobacter spp. clinical isolates from the UK
Michel Doumith et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
β-Lactam Resistance Response Triggered by Inactivation of a Nonessential Penicillin-Binding Protein
Bartolome Moya et al.
PLOS PATHOGENS (2009)
Inhibitors of bacterial multidrug efflux pumps potentiate antimicrobial photoinactivation
George P. Tegos et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
Sulbactam-containing beta-lactamase inhibitor combinations
M. Akova
CLINICAL MICROBIOLOGY AND INFECTION (2008)
Phenotypic characterization of pore mutants of the Vibrio cholerae porin OmpU
Melissa Pagel et al.
JOURNAL OF BACTERIOLOGY (2007)
Piperacillin-tazobactam:: a β-lactam/β-lactamase inhibitor combination
Alfred Gin et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2007)
Genome sequencing reveals complex secondary metabolome in the marine actinomycete Salinispora tropica
Daniel W. Udwary et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Beta lactam antibiotic monotherapy versus beta lactamaminoglycoside antibiotic combination therapy for sepsis
M Paul et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2006)
The prokaryotic enzyme DsbB may share key structural features with eukaryotic disulfide bond forming oxidoreductases
CS Sevier et al.
PROTEIN SCIENCE (2005)
β-lactam antibiotic resistance:: a current structural perspective
MS Wilke et al.
CURRENT OPINION IN MICROBIOLOGY (2005)
In vitro activity and killing effect of temporin A on nosocomial isolates of Enterococcus faecalis and interactions with clinically used antibiotics
A Giacometti et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Irreversible inhibition of metallo-beta-lactamase (IMP-1) by 3-(3-mercaptopropionylsulfanyl)propionic acid pentafluorophenyl ester
H Kurosaki et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2005)
In vitro activity of AVE1330A, an innovative broad-spectrum non-β-lactam β-lactamase inhibitor
A Bonnefoy et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Modulation of β-lactam resistance in Staphylococcus aureus by catechins and gallates
PD Stapleton et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2004)
Imipenem and expression of multidrug efflux pump in Enterobacter aerogenes
C Bornet et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Increase of the deacylation rate of PBP2x from Streptococcus pneumoniae by single point mutations mimicking the class A beta-lactamases
L Chesnel et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2002)
Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-OprM efflux pumps in Pseudomonas aeruginosa
N Masuda et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Chromosomal beta-lactamase is packaged into membrane vesicles and secreted from Pseudomonas aeruginosa
O Ciofu et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2000)
分享论文
